Navigation Links
Seminar Spotlights Key Trends in Biologics and Biosimilars
Date:3/12/2013

BURLINGTON, Mass., March 12, 2013 /PRNewswire/ -- Decision Resources Group (DRG) invites pharmaceutical professionals to a one-day seminar of in-depth analysis covering key issues in the biologics and biosimilars market. The seminar, which will include presentations from prominent DRG analysts and an industry panel discussion, will be held May 2, 2013 at Hotel Solamar in San Diego, CA.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36768LOGO )

Andrew Merron , Ph.D., Director of the Biosimilars Advisory Service at Decision Resources Group, a recognized expert in the area of biologics and biosimilars, explained the timeliness of the seminar. "Though the first generation of biosimilar products experienced mixed commercial success in Europe, substantial commercial opportunity remains for future biosimilar agents across a wide variety of indications and new biologics continue to carve out niches and evolve current standards of care,"  said Dr. Merron.

Presentations at the seminar will address market trends and opportunities. Dr. Merron noted, "Sales of biologics have continued to grow globally despite increasing competition from biosimilars. However, developers of new branded biologics are now challenged to demonstrate clinical differentiation and developers of biosimilars are challenged to meet robust clinical comparability requirements."

This seminar is intended for pharmaceutical professionals involved in market research, business development and competitive intelligence.  Attendees are invited to engage with analysts and peers with a post-event reception

For more information about the topics and speakers at the seminar go to http://www.competi
'/>"/>

SOURCE Decision Resources Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists
2. ComplianceOnline Announces Seminar on Clinical Trial Project Supplier Quality Improvement
3. ComplianceOnline Announces Seminar on Statistical Analysis for Product Development
4. Patheon to Host Complimentary Seminar on “Getting Your Drug through Phase I Early Development Effectively” at Milton Park, UK Facility
5. BioSpace Spotlights Northwests Life Science Community
6. BioSpace Spotlights Leading Life Science Community
7. FasterCures Spotlights Addario Lung Cancer Medical Institutes Innovative Research Programs
8. BioSpace Spotlights the growing Midwest Life Science Community
9. BioSpace Spotlights Thriving Bay Area Life Science Community
10. BioSpace Spotlights Northwests Life Science Community
11. ResearchMoz: MicroRNA Market Trends 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... Cambridge, MA (PRWEB) May 28, 2015 ... provider located in Basel, Switzerland, and the ... (ACRES), a Cambridge, Massachusetts-based non-profit organization operating ... building a global system to enhance quality, ... product development and health research, are pleased ...
(Date:5/27/2015)... May 26, 2015 Research and Markets( ... "Global Breast Cancer Monoclonal Antibodies Market Outlook ... Globally, Roche seems to dominate the breast cancer ... block buster molecule, Herceptin has been able to ... found that breast cancer cells become recalcitrant and ...
(Date:5/27/2015)... , May 27, 2015  Tikcro Technologies Ltd. (OTCQB: ... March 31, 2015. Aviv Boim ... continued pre-clinical work to generate functional specific antibodies, targeting ... stage, we are encouraged by the development progress. We ... new antibodies which modulate immune checkpoints gain clinical acceptance ...
(Date:5/27/2015)... -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO ) ("NW Bio"), ... cancer, announced today that Dr. Marnix L. Bosch ... making an Industry Expert Theater Presentation at the 2015 ... on Saturday, May 30, 2015, from 3 to 4 ... Place. Dr. Bosch will provide an overview ...
Breaking Biology Technology:Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 2Clinerion and ACRES Partner on Patient Recruitment and Risk-Based Quality Management 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3Tikcro Technologies Reports First Quarter 2015 Results 2Tikcro Technologies Reports First Quarter 2015 Results 3NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 2NW Bio To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend 3
... ReportsnReports announces it will carry , , Daptomycin ... Browse the complete , , Daptomycin - Comprehensive patent,search ... Market Research,Reports Browse All ... Eliminate unnecessary risk with the industry benchmark in,comprehensive patent information. ...
... nation,s long-term clean-energy future, but the technology has come ... Fukushima disaster. Indeed, many nations have called for checks ... safely. In the United States, about 20 ... the electricity from emission-free sources, including renewable technologies and ...
... Cebix Incorporated announced today that preclinical data for ... demonstrated a half-life of three days as compared to ... in nerve conduction velocity, a measure of the rate ... an animal model of diabetic peripheral neuropathy. Additionally, clinical ...
Cached Biology Technology:ReportsnReports - Daptomycin - Comprehensive Patent Search 2ReportsnReports - Daptomycin - Comprehensive Patent Search 3ReportsnReports - Daptomycin - Comprehensive Patent Search 4ReportsnReports - Daptomycin - Comprehensive Patent Search 5Berkeley scientists pioneer nanoscale nuclear materials testing capability 2Cebix's Long-Acting C-Peptide Ersatta™ has Potential in Multiple Chronic Complications of Diabetes 2Cebix's Long-Acting C-Peptide Ersatta™ has Potential in Multiple Chronic Complications of Diabetes 3
(Date:5/21/2015)... 21, 2015 The Sync Project™ , ... for health, today announced a collaborative partnership with ... will center on collaboration on original research, joint course ... in the collaboration, The Sync Project and BerkleeICE are ... Medicine" in the 2015-2016 academic year.  ...
(Date:5/19/2015)... Research and Markets ( ... the  "Genetic Testing Market Outlook 2018"  report ... ,A recent report, Genetic Testing Market Outlook ... current and future genetic testing market. A ... principles and types are covered in this ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3Global Genetic Testing Market Outlook 2018 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... and ecological sustainability of biofuels and the impact of ... America will take place on Friday, Dec. 5, in ... Neotropical Forests: Trends, Implications and Emerging Alternatives, is sponsored ... the Program in Native Species Reforestation, both joint programs ...
... Associated Professor, DSc Barbara Ann Halkier, Department of ... Life Sciences, University of Copenhagen, has been granted ... award for her excellent research into secondary metabolites, ... plants. In particular, her research has focused ...
... Company Experiences Record Revenue Growth from Operations in Third Quarter , ... bioMETRX, Inc. (OTC Bulletin Board: BMRX), a leading developer of consumer-based ... ending September 30, 2008. , , ... 430% increase over second quarter revenues of $100,000. , ...
Cached Biology News:Conference to explore sustainability of biofuels 2The Danisco Award 2008 goes to D.Sc. Barbara Ann Halkier from Faculty of Life Sciences, Copenhagen 2bioMETRX, Inc. Highlights 3rd Quarter 2008 Financial Results 2
Mouse monoclonal antibody raised against a partial recombinant AAAS. NCBI Entrez Gene ID = AAAS...
Rabbit polyclonal to MCP2 ( Abpromise for all tested applications). entrezGeneID: 6355 SwissProtID: P49873...
... A sensitive and high speed homogeneous ... phosphatase activity and for screening of inhibitors ... kit is based on a fluorescence superquenching ... radioactive label. The universal platform provides flexibility ...
... PowerPac 3000 power supply, 220-240 V, is ... liquid-phase isoelectric focusing (IEF). The system includes ... (60 ml) focusing chambers, chassis, harvesting apparatus, ... supply, 10 ml Bio-Lyte ampholytes (pH 3-10), ...
Biology Products: